LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 20

Search options

  1. Article ; Online: Neurological involvement of coronavirus disease 2019: a systematic review.

    Ghannam, Malik / Alshaer, Qasem / Al-Chalabi, Mustafa / Zakarna, Lara / Robertson, Jetter / Manousakis, Georgios

    Journal of neurology

    2020  Volume 267, Issue 11, Page(s) 3135–3153

    Abstract: ... the Coronavirus Disease 2019 (COVID-2019) outbreak, a pandemic.: Objective: To clarify the neurological ... We conducted a systematic literature search from December 01, 2019 to May 14, 2020 using multiple combinations ... involvement was evident.: Results: We were able to identify 82 cases of COVID-19 with neurological ...

    Abstract Background: In December 2019, unexplained cases of pneumonia emerged in Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On March 11, 2020, the WHO declared the Coronavirus Disease 2019 (COVID-2019) outbreak, a pandemic.
    Objective: To clarify the neurological complications of SARS-CoV-2 infection including the potential mechanisms and therapeutic options.
    Methods: We conducted a systematic literature search from December 01, 2019 to May 14, 2020 using multiple combinations of keywords from PubMed and Ovid Medline databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included articles with cases of COVID-19 where neurological involvement was evident.
    Results: We were able to identify 82 cases of COVID-19 with neurological complications. The mean age was 62.3 years. 37.8% of the patients were women (n = 31). 48.8% of the patients (n = 40) had cerebrovascular insults, 28% (n = 23) had neuromuscular disorders, and 23% of the patients (n = 19) had encephalitis or encephalopathy.
    Conclusions: Neurological manifestations of COVID-19 are not rare, especially large vessel stroke, Guillain-Barre syndrome, and meningoencephalitis. Moving forward, further studies are needed to clarify the prevalence of the neurological complications of SARS-CoV-2 infection, investigate their biological backgrounds, and test treatment options. Physicians should be cautious not to overlook other neurological diagnoses that can mimic COVID-19 during the pandemic.
    MeSH term(s) Adult ; Aged ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Female ; Humans ; Male ; Middle Aged ; Nervous System Diseases/epidemiology ; Nervous System Diseases/virology ; Pandemics ; Pneumonia, Viral/complications ; Prevalence ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-06-19
    Publishing country Germany
    Document type Journal Article ; Systematic Review
    ZDB-ID 187050-6
    ISSN 1432-1459 ; 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    ISSN (online) 1432-1459
    ISSN 0340-5354 ; 0012-1037 ; 0939-1517 ; 1619-800X
    DOI 10.1007/s00415-020-09990-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Neurological involvement of coronavirus disease 2019: a systematic review

    Ghannam, Malik / Alshaer, Qasem / Al-Chalabi, Mustafa / Zakarna, Lara / Robertson, Jetter / Manousakis, Georgios

    J. neurol

    Abstract: ... the Coronavirus Disease 2019 (COVID-2019) outbreak, a pandemic. OBJECTIVE: To clarify the neurological ... We conducted a systematic literature search from December 01, 2019 to May 14, 2020 using multiple combinations ... involvement was evident. RESULTS: We were able to identify 82 cases of COVID-19 with neurological ...

    Abstract BACKGROUND: In December 2019, unexplained cases of pneumonia emerged in Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On March 11, 2020, the WHO declared the Coronavirus Disease 2019 (COVID-2019) outbreak, a pandemic. OBJECTIVE: To clarify the neurological complications of SARS-CoV-2 infection including the potential mechanisms and therapeutic options. METHODS: We conducted a systematic literature search from December 01, 2019 to May 14, 2020 using multiple combinations of keywords from PubMed and Ovid Medline databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We included articles with cases of COVID-19 where neurological involvement was evident. RESULTS: We were able to identify 82 cases of COVID-19 with neurological complications. The mean age was 62.3 years. 37.8% of the patients were women (n = 31). 48.8% of the patients (n = 40) had cerebrovascular insults, 28% (n = 23) had neuromuscular disorders, and 23% of the patients (n = 19) had encephalitis or encephalopathy. CONCLUSIONS: Neurological manifestations of COVID-19 are not rare, especially large vessel stroke, Guillain-Barre syndrome, and meningoencephalitis. Moving forward, further studies are needed to clarify the prevalence of the neurological complications of SARS-CoV-2 infection, investigate their biological backgrounds, and test treatment options. Physicians should be cautious not to overlook other neurological diagnoses that can mimic COVID-19 during the pandemic.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32561990
    Database COVID19

    Kategorien

  3. Article ; Online: Neurological Manifestations in COVID-19 Infection

    Collantes, Maria Epifania V. / Espiritu, Adrian I. / Sy, Marie Charmaine C. / Anlacan, Veeda Michelle M. / Jamora, Roland Dominic G.

    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

    A Systematic Review and Meta-Analysis

    2020  , Page(s) 1–11

    Abstract: ABSTRACT: Background: Growing evidence showed that coronavirus disease 2019 (COVID-19) infection ... This review revealed that neurologic involvement may manifest in COVID-19 infection. What has initially been ... manifestations and complications in COVID-19. Methods: We conducted a systematic review and meta-analysis ...

    Abstract ABSTRACT: Background: Growing evidence showed that coronavirus disease 2019 (COVID-19) infection may present with neurological manifestations. This review aimed to determine the neurological manifestations and complications in COVID-19. Methods: We conducted a systematic review and meta-analysis that included cohort and case series/reports involving a population of patients confirmed with COVID-19 infection and their neurologic manifestations. We searched the following electronic databases until April 18, 2020: PubMed, Embase, Scopus, and World Health Organization database (PROSPERO registration number: CRD42020180658). Results: From 403 articles identified, 49 studies involving a total of 6,335 confirmed COVID-19 cases were included. The random-effects modeling analysis for each neurological symptom showed the following proportional point estimates with 95% confidence intervals: “headache” (0.12; 0.10–0.14; I 2 = 77%), “dizziness” (0.08; 0.05–0.12; I 2 = 82%), “headache and dizziness” (0.09; 0.06–0.13; I 2 = 0%), “nausea” (0.07; 0.04–0.11; I 2 = 79%), “vomiting” (0.05; 0.03–0.08; I 2 = 74%), “nausea and vomiting” (0.06; 0.03–0.11; I 2 = 83%), “confusion” (0.05; 0.02–0.14; I 2 = 86%), and “myalgia” (0.21; 0.18–0.25; I 2 = 85%). The most common neurological complication associated with COVID-19 infection was vascular disorders ( n = 23); other associated conditions were encephalopathy ( n = 3), encephalitis ( n = 1), oculomotor nerve palsy ( n = 1), isolated sudden-onset anosmia ( n = 1), Guillain–Barré syndrome ( n = 1), and Miller–Fisher syndrome ( n = 2). Most patients with neurological complications survived ( n = 14); a considerable number of patients died ( n = 7); and the rest had unclear outcomes ( n = 12). Conclusion: This review revealed that neurologic involvement may manifest in COVID-19 infection. What has initially been thought of as a primarily respiratory illness has evolved into a wide-ranging multi-organ disease.
    Keywords Neurology ; Clinical Neurology ; General Medicine ; covid19
    Language English
    Publisher Cambridge University Press (CUP)
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 197622-9
    ISSN 0317-1671
    ISSN 0317-1671
    DOI 10.1017/cjn.2020.146
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Neurological Manifestations of Coronavirus Disease 2019 and Mpox in Pediatric Patients and Their Management: A State-of-the-Art Systematic Review.

    Deb, Novonil / Roy, Poulami / Biswakarma, Anuradha / Mary, Therese / Mahajan, Sanah / Khan, Javeria / Shah, Aatam

    Pediatric neurology

    2023  Volume 146, Page(s) 65–78

    Abstract: ... manifestations of Coronavirus disease 2019 (COVID-19) infection and Monkeypox (Mpox), both during the course of the infection ... monkeypox in pediatric patients and their management.: Methods: We conducted a systematic review ... and as a presenting symptom. We aim to review the neurological manifestations of COVID-19 and ...

    Abstract Background: There is an increasing number of cases being reported of neurological manifestations of Coronavirus disease 2019 (COVID-19) infection and Monkeypox (Mpox), both during the course of the infection and as a presenting symptom. We aim to review the neurological manifestations of COVID-19 and monkeypox in pediatric patients and their management.
    Methods: We conducted a systematic review that included cohort studies and case series or reports involving a pediatric population of patients with a confirmed COVID-19 or Mpox infection and their neurological manifestations. We searched the following electronic databases: PubMed, EMBASE, and Scopus.
    Results: From 1136 articles identified, 127 studies were included. Headache, stroke, Guillain-Barré syndrome, seizure, nerve palsies, and multisystem inflammatory syndrome in children were the most common neurological symptoms caused by COVID-19, whereas encephalitis was commonly seen in patients with Mpox. Rare neurological manifestations of COVID-19 included cerebral venous sinus thrombosis, plexopathies, demyelinating disorders, encephalitis, etc., and rare neurological manifestations of Mpox included headache.
    Conclusions: Our review highlights the importance of investigating possible neurological manifestations and closely monitoring these patients to develop a better understanding of the treatment strategies that can be adopted.
    MeSH term(s) Humans ; Child ; COVID-19/complications ; Mpox (monkeypox)/complications ; Nervous System Diseases/epidemiology ; SARS-CoV-2 ; Headache/etiology ; Encephalitis/etiology
    Language English
    Publishing date 2023-05-19
    Publishing country United States
    Document type Systematic Review ; Journal Article
    ZDB-ID 639164-3
    ISSN 1873-5150 ; 0887-8994
    ISSN (online) 1873-5150
    ISSN 0887-8994
    DOI 10.1016/j.pediatrneurol.2023.05.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Neurological Involvement in COVID-19 Patients

    Ramakant Yadav / Dhiraj Kumar Srivastava / Prashant Kumar Bajpai / Raj Kumar

    Journal of Neurosciences in Rural Practice, Vol 11, Iss 04, Pp 526-

    A Narrative Review

    2020  Volume 529

    Abstract: Background Coronavirus disease 2019 (COVID-19) is a viral disease caused ... a narrative review done using techniques of systemic review, that is, Preferred Reporting Items for Systematic ... of neurological involvement. Most common central nervous system symptoms reported were headache, followed ...

    Abstract Background Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belonging to the coronavirus family. The primary target of SARS-CoV-2 is peripheral mucosal cells of respiratory tract. Recent days have seen few cases where virus has affected extrapulmonary organ such as nervous system. Materials and Methods The present study was a narrative review done using techniques of systemic review, that is, Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases such as PubMed (Medline) and Google Scholar were searched systematically for published article from December 1, 2019 to June 5, 2020. A total of 189 articles were initially selected by the authors. A final list of 17 articles was prepared and following information were extracted from selected studies: study design, main result, and limitations of the study. Results Majority of these article were descriptive studies describing spectrum of signs and symptoms among admitted patients. In majority of these studies, patients have developed symptoms suggestive of neurological involvement. Most common central nervous system symptoms reported were headache, followed by dizziness and confusion. Similarly, the most common peripheral nervous system involvement was loss of taste and smell. Conclusion The present study concludes that there are enough evidences to prove that SARS-CoV-2 infection affects both central and peripheral nervous system. Various mechanisms are proposed to explain the pathophysiology of neurological manifestations in COVID-19-positive patients that needs to be established and verified.
    Keywords coronavirus infections ; sars-cov-2 ; neurological involvement and its manifestations ; Neurosciences. Biological psychiatry. Neuropsychiatry ; RC321-571 ; covid19
    Subject code 610
    Language English
    Publishing date 2020-09-01T00:00:00Z
    Publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Neurological Involvement in COVID-19 Patients

    Yadav, Ramakant / Srivastava, Dhiraj Kumar / Bajpai, Prashant Kumar / Kumar, Raj

    Journal of Neurosciences in Rural Practice

    A Narrative Review

    2020  Volume 11, Issue 04, Page(s) 526–529

    Abstract: Abstract Background Coronavirus disease 2019 (COVID-19) is a viral disease caused ... a narrative review done using techniques of systemic review, that is, Preferred Reporting Items for Systematic ... of neurological involvement. Most common central nervous system symptoms reported were headache, followed ...

    Abstract Abstract Background Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belonging to the coronavirus family. The primary target of SARS-CoV-2 is peripheral mucosal cells of respiratory tract. Recent days have seen few cases where virus has affected extrapulmonary organ such as nervous system. Materials and Methods The present study was a narrative review done using techniques of systemic review, that is, Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases such as PubMed (Medline) and Google Scholar were searched systematically for published article from December 1, 2019 to June 5, 2020. A total of 189 articles were initially selected by the authors. A final list of 17 articles was prepared and following information were extracted from selected studies: study design, main result, and limitations of the study. Results Majority of these article were descriptive studies describing spectrum of signs and symptoms among admitted patients. In majority of these studies, patients have developed symptoms suggestive of neurological involvement. Most common central nervous system symptoms reported were headache, followed by dizziness and confusion. Similarly, the most common peripheral nervous system involvement was loss of taste and smell. Conclusion The present study concludes that there are enough evidences to prove that SARS-CoV-2 infection affects both central and peripheral nervous system. Various mechanisms are proposed to explain the pathophysiology of neurological manifestations in COVID-19-positive patients that needs to be established and verified.
    Keywords General Neuroscience ; Clinical Neurology ; covid19
    Language English
    Publisher Georg Thieme Verlag KG
    Publishing country de
    Document type Article ; Online
    ZDB-ID 2601242-X
    ISSN 0976-3155 ; 0976-3147
    ISSN (online) 0976-3155
    ISSN 0976-3147
    DOI 10.1055/s-0040-1716423
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Neurological findings in patients with COVID-19

    Ar Rochmah, Mawaddah / Satiti, Sekar / Setyopranoto, Ismail / Harahap, Indra Sari Kusuma / Sejahtera, Desin Pambudi / Nugroho, Dhite Bayu / Sutarni, Sri

    Journal of the Medical Sciences (Berkala ilmu Kedokteran); Vol 52, No; 2356-3931 ; 0126-1312

    a systematic review

    2020  Volume 3, Issue : Special Issue: COVID-19

    Abstract: ... in Wuhan, China at the end of 2019, the coronavirus disease 2019 (COVID-19) has become pandemic for months ... This paper aimed to review the neurological findings reported in patients with COVID-19. We qualitatively ... cerebrovascular diseases, Guillain-Barré syndrome, and Miller Fisher syndrome. This review suggests the possible ...

    Abstract Since the emerging of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in Wuhan, China at the end of 2019, the coronavirus disease 2019 (COVID-19) has become pandemic for months. Due to fast increased number of the positive patients with COVID-19, SARS-CoV-2 is considered highly pathogenic virus with various clinical presentations. Apart from the typical respiratory symptoms, neurological complains in COVID-19 involving central and peripheral nervous systems have been reported. This paper aimed to review the neurological findings reported in patients with COVID-19. We qualitatively reviewed studies reporting COVID-19 patient(s) with neurological manifestations according to the recommendations of PRISMA statement.There were twelve studies included in this brief review. We found that patients with neurological findings were reported ranging from symptomatic complain of headache and dizziness to specific neurological diseases/syndromes, such as meningitis/encephalitis, acute cerebrovascular diseases, Guillain-Barré syndrome, and Miller Fisher syndrome. This review suggests the possible neurological involvement in COVID-19. We hope to raise the awareness of the health workers in taking care of the patients with COVID-19 and neurological diseases.
    Keywords SARS-CoV-2 ; Covid-19 ; neurological findings ; nervous system ; covid19
    Subject code 610
    Language English
    Publishing date 2020-05-14
    Publisher Journal of the Medical Sciences (Berkala ilmu Kedokteran)
    Publishing country id
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Neurological findings in patients with COVID-19

    Mawaddah Ar Rochmah / Sekar Satiti / Ismail Setyopranoto / Indra Sari Kusuma Harahap / Desin Pambudi Sejahtera / Dhite Bayu Nugroho / Sri Sutarni

    Journal of the Medical Sciences, Vol 52, Iss

    a systematic review

    2020  Volume 3

    Abstract: ... in Wuhan, China at the end of 2019, the coronavirus disease 2019 (COVID-19) has become pandemic for months ... This paper aimed to review the neurological findings reported in patients with COVID-19. We qualitatively ... cerebrovascular diseases, Guillain-Barré syndrome, and Miller Fisher syndrome. This review suggests the possible ...

    Abstract Since the emerging of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in Wuhan, China at the end of 2019, the coronavirus disease 2019 (COVID-19) has become pandemic for months. Due to fast increased number of the positive patients with COVID-19, SARS-CoV-2 is considered highly pathogenic virus with various clinical presentations. Apart from the typical respiratory symptoms, neurological complains in COVID-19 involving central and peripheral nervous systems have been reported. This paper aimed to review the neurological findings reported in patients with COVID-19. We qualitatively reviewed studies reporting COVID-19 patient(s) with neurological manifestations according to the recommendations of PRISMA statement.There were twelve studies included in this brief review. We found that patients with neurological findings were reported ranging from symptomatic complain of headache and dizziness to specific neurological diseases/syndromes, such as meningitis/encephalitis, acute cerebrovascular diseases, Guillain-Barré syndrome, and Miller Fisher syndrome. This review suggests the possible neurological involvement in COVID-19. We hope to raise the awareness of the health workers in taking care of the patients with COVID-19 and neurological diseases.
    Keywords sars-cov-2 ; covid-19 ; neurological findings ; nervous system ; Medicine ; R ; covid19
    Subject code 610
    Language English
    Publishing date 2020-05-01T00:00:00Z
    Publisher Universitas Gadjah Mada
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Neurological manifestations in COVID-19: a systematic review and meta-analysis.

    Chua, Tzy Harn / Xu, Zheyu / King, Nicolas Kon Kam

    Brain injury

    2020  Volume 34, Issue 12, Page(s) 1549–1568

    Abstract: Objective: Following the outbreak of coronavirus 2019 (COVID-19), there is strong evidence ... of neurological manifestations in COVID-19.: Method: A systematic review of studies reporting neurological ... of neurological involvement in these patients. We aimed to determine the clinical characteristics ...

    Abstract Objective: Following the outbreak of coronavirus 2019 (COVID-19), there is strong evidence of neurological involvement in these patients. We aimed to determine the clinical characteristics of neurological manifestations in COVID-19.
    Method: A systematic review of studies reporting neurological manifestations published between 1 December, 2019 and 11 May, 2020 was performed. Studies were grouped based on neurological manifestation. Pooled analyses of individual patient's clinical characteristics and olfactory and gustatory dysfunction prevalence were performed.
    Results: Of 486 studies identified, 48 were included. 70 patients with 73 neurological manifestations were reported. 39 (53.4%) patients had stroke, 18 (24.7%) had Guillain-Barré syndrome and variants, 11 (15.1%) had meningitis, encephalitis, encephalopathy, or myelitis, and five (6.8%) had seizures. They had a mean age of 61.9 ± 17.7 years (60.6% male). Neurological disease occurred 8.1 ± 6.8 days from initial symptoms. Average mortality rate was 17.8%. Stroke has a mortality rate of 25.6%. Olfactory and gustatory dysfunction occurred in 59.9% and 57.5%, respectively.
    Conclusions: Stroke is the most frequently reported neurological manifestation in COVID-19 and has the highest mortality rate. Neurological manifestations tend to develop one to two weeks after the onset of respiratory disease. There is significant morbidity and mortality associated with COVID-19 neurological manifestations.
    MeSH term(s) COVID-19/complications ; Cerebrovascular Disorders/etiology ; Encephalitis/etiology ; Guillain-Barre Syndrome/etiology ; Humans ; Nervous System Diseases/etiology
    Keywords covid19
    Language English
    Publishing date 2020-10-19
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 639115-1
    ISSN 1362-301X ; 0269-9052
    ISSN (online) 1362-301X
    ISSN 0269-9052
    DOI 10.1080/02699052.2020.1831606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis.

    Collantes, Maria Epifania V / Espiritu, Adrian I / Sy, Marie Charmaine C / Anlacan, Veeda Michelle M / Jamora, Roland Dominic G

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

    2020  Volume 48, Issue 1, Page(s) 66–76

    Abstract: Background: Growing evidence showed that coronavirus disease 2019 (COVID-19) infection may present ... 12).: Conclusion: This review revealed that neurologic involvement may manifest in COVID-19 ... Methods: We conducted a systematic review and meta-analysis that included cohort and case series/reports ...

    Abstract Background: Growing evidence showed that coronavirus disease 2019 (COVID-19) infection may present with neurological manifestations. This review aimed to determine the neurological manifestations and complications in COVID-19.
    Methods: We conducted a systematic review and meta-analysis that included cohort and case series/reports involving a population of patients confirmed with COVID-19 infection and their neurologic manifestations. We searched the following electronic databases until April 18, 2020: PubMed, Embase, Scopus, and World Health Organization database (PROSPERO registration number: CRD42020180658).
    Results: From 403 articles identified, 49 studies involving a total of 6,335 confirmed COVID-19 cases were included. The random-effects modeling analysis for each neurological symptom showed the following proportional point estimates with 95% confidence intervals: "headache" (0.12; 0.10-0.14; I2 = 77%), "dizziness" (0.08; 0.05-0.12; I2 = 82%), "headache and dizziness" (0.09; 0.06-0.13; I2 = 0%), "nausea" (0.07; 0.04-0.11; I2 = 79%), "vomiting" (0.05; 0.03-0.08; I2 = 74%), "nausea and vomiting" (0.06; 0.03-0.11; I2 = 83%), "confusion" (0.05; 0.02-0.14; I2 = 86%), and "myalgia" (0.21; 0.18-0.25; I2 = 85%). The most common neurological complication associated with COVID-19 infection was vascular disorders (n = 23); other associated conditions were encephalopathy (n = 3), encephalitis (n = 1), oculomotor nerve palsy (n = 1), isolated sudden-onset anosmia (n = 1), Guillain-Barré syndrome (n = 1), and Miller-Fisher syndrome (n = 2). Most patients with neurological complications survived (n = 14); a considerable number of patients died (n = 7); and the rest had unclear outcomes (n = 12).
    Conclusion: This review revealed that neurologic involvement may manifest in COVID-19 infection. What has initially been thought of as a primarily respiratory illness has evolved into a wide-ranging multi-organ disease.
    MeSH term(s) Anosmia/etiology ; Anosmia/physiopathology ; Brain Diseases/etiology ; Brain Diseases/physiopathology ; COVID-19/complications ; COVID-19/physiopathology ; Cerebral Hemorrhage/etiology ; Cerebral Hemorrhage/physiopathology ; Cerebral Infarction/etiology ; Cerebral Infarction/physiopathology ; Cerebrovascular Disorders/etiology ; Cerebrovascular Disorders/physiopathology ; Confusion/etiology ; Confusion/physiopathology ; Dizziness/etiology ; Dizziness/physiopathology ; Encephalitis/etiology ; Encephalitis/physiopathology ; Guillain-Barre Syndrome/etiology ; Guillain-Barre Syndrome/physiopathology ; Headache/etiology ; Headache/physiopathology ; Humans ; Myalgia/etiology ; Myalgia/physiopathology ; Nausea/etiology ; Nausea/physiopathology ; Oculomotor Nerve Diseases/etiology ; Oculomotor Nerve Diseases/physiopathology ; SARS-CoV-2 ; Sinus Thrombosis, Intracranial/etiology ; Sinus Thrombosis, Intracranial/physiopathology ; Vomiting/etiology ; Vomiting/physiopathology
    Keywords covid19
    Language English
    Publishing date 2020-07-15
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 197622-9
    ISSN 0317-1671
    ISSN 0317-1671
    DOI 10.1017/cjn.2020.146
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top